Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Purple Biotech Ltd. AGM Information 2017

Nov 1, 2017

7004_rns_2017-11-01_64cb50bd-bff1-4958-a22a-a25e57d5e223.pdf

AGM Information

Open in viewer

Opens in your device viewer

Voting Slip – Part Two

Company name: Kitov Pharmaceuticals Holdings Limited, public company no. 520031238

Company address (for submission and delivery of Voting Slips): One Azrieli Center, Round Tower, 19th Floor, Tel Aviv 6701101, Israel

Meeting date: Monday, December 4, 2017, at 4:30 p.m. (Israel Time).

Date of adjourned meeting: Monday, December 11, 2017, at 4:30 p.m. (Israel Time).

Meeting type: Annual General Meeting (the "Meeting").

Shareholder Details:

Shareholder Name:

Israeli ID no.:

For shareholders who are not in possession of an Israeli ID card:

Passport no ::

Country of Issue:

Valid Until:

For shareholders that are corporations:

Corporation no. : ____________________________________________________________________________________________________________________________________________________________

Country of Incorporation:

Is the Shareholder any of the following [1]:

A "Principal Shareholder"]!: Yes / No
A "Senior Officer of the Company"14: Yes / No
An "Institutional Investor"31. Yes / No

l

2

3

4 As defined in Regulation 1 of the Supervision of Financial Services Regulations (Provident Funds)(Participation of a Management Company at a General Meeting), 5769-2009 as well as a Manager of Mutual Funds as per the meaning in the Mutual Funds Law, 5754-1999

18

Manner of Voting:

Manner of voting
Matter For Against Abstain
Proposal 2
To approve the re-appointment of Somekh Chaikin, Certified
Public Accountants (Israel), a member of KPMG International, as
the independent public accountants of the Company, for three
years until the 2020 Annual General Meeting of the shareholders
of the Company, and to authorize the Audit Committee of the
Board of Directors of the Company to fix the compensation of said
auditors in accordance with the scope and nature of their services.
Proposal 3
To approve a change of the Company's name to "Kitov Pharma
Ltd." or such similar name containing the name "Kitov" as
determined by the Company's management and approved by the
Israeli Registrar of Companies, and to approve the applicable
amendments to each of the Company's Memorandum of
Association and amended and restated articles of association to
reflect such name change (the change of the Company's name will
be effective only following the approval and authorization of the
Israeli Registrar of Companies).
Proposal 4
To approve the re-appointment of the applicable nominee for re-
election as a director, to serve as a director of the Company in the
second class of directors, commencing with the expiration of the
applicable nominee's current term of office as a director, and to
serve until the 2020 annual meeting of shareholders of the
Company, and until his successor has been duly appointed, at
which time his term of office will end as set forth in the
Company's amended and restated articles of association.
Proposal 4.A.
Mr. Ido Agmon
Proposal 4.B.
Mr. Steven Steinberg
Proposal 4.C.
Mr. Ran Tzror

Mark X or V clearly in the appropriate column, in accordance with your voting decision.

Date

Signature

For shareholders holding shares through a stock exchange member (in accordance with Section 177(1) of the Companies Law, 5799 - 1999), this Voting Slip is only valid when accompanied by an certification of ownership. For shareholders registered in the Company's shareholder registry – this Voting Slip will only be valid when accompanied by a photocopy of an ID / passport / certificate of incorporation.

19